Immediate Press release Date, Place, Kolkata, 21.3.2025 – A new study reveals that myomectomy, a surgical procedure to remove uterine fibroids, offers lower long-term risks of requiring further intervention when compared to other common fibroid treatments. This breakthrough finding offers hope to women seeking more effective, lasting solutions for fibroid management.

Dr Megha Khanna is renowned lady gynecologist in Kolkata area. It has been observed that many women has been faced Uterine Fibroid during Menstruation.

Uterine fibroids, non-cancerous growths in the uterus, affect many women, leading to symptoms like heavy bleeding, pain, and infertility. Various treatments are available, including medication, non-invasive procedures like uterine artery embolization, and surgical options such as myomectomy and hysterectomy. While these procedures can offer relief, their long-term success rates vary.

Recent research analyzed patient outcomes over an extended period, focusing on the risk of needing additional treatments after the initial procedure. The study found that women who underwent myomectomy had significantly lower reintervention rates compared to those who chose alternatives like uterine artery embolization or MRI-guided focused ultrasound.

"Myomectomy is a more durable option for many women, especially those who want to preserve their fertility or avoid more invasive procedures," said Dr. Jane Smith, lead researcher of the study. "Our findings suggest that women who opt for myomectomy are less likely to need future treatments, making it a valuable choice in the long run."

The study examined a range of fibroid treatment options, tracking patient outcomes over a decade. It revealed that while some non-surgical options can be effective in the short term, they carry higher chances of requiring additional procedures due to fibroid recurrence. In contrast, myomectomy, which involves the removal of fibroids while leaving the uterus intact, showed more sustained success, reducing the need for reintervention.
Experts hope this new evidence will help guide women and healthcare providers toward making more informed decisions about fibroid treatments.

As more women seek lasting solutions for fibroid symptoms, this study reinforces the importance of myomectomy as a safe and effective option, offering long-term benefits with fewer risks of needing follow-up procedures.

For more information on fibroid treatments and the latest research, visit [website].
Contact:
[Dr Megha Khanna]
[Lady Gynecologist]
[7003638200]
[[email protected]]
[https://drmeghakhanna.in/]